cephalosporin c has been researched along with dactinomycin in 125 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (12.00) | 18.7374 |
| 1990's | 48 (38.40) | 18.2507 |
| 2000's | 42 (33.60) | 29.6817 |
| 2010's | 18 (14.40) | 24.3611 |
| 2020's | 2 (1.60) | 2.80 |
| Authors | Studies |
|---|---|
| Lechevalier, HA | 1 |
| Demain, AL; Drew, SW | 1 |
| Vining, LC | 1 |
| Hahn, FE | 1 |
| Bodanszky, M; Perlman, D | 1 |
| Gröger, D; Maier, W | 1 |
| Kurahashi, K | 1 |
| Arai, S; Kikuchi, M; Kudo, A; Kumagai, K; Yuri, Y | 1 |
| Berridge, NJ; Jarvis, B | 1 |
| Waksman, SA | 1 |
| Russell, AD | 1 |
| Yudkin, MD | 2 |
| Davies, JW | 1 |
| DAY, RA; SHAH, R; YIP, LC | 1 |
| Imada, A; Kita, Y; Yamazaki, T | 1 |
| Imada, A; Iwahi, T; Kondo, M; Miyake, A; Okonogi, K; Shiki, S; Yamazaki, T | 1 |
| Hashimoto, N; Imada, A; Miyake, A; Nishimura, T; Yamaoka, M; Yoshimura, Y | 1 |
| Iwahi, T; Nakao, M; Noji, Y; Yamazaki, T | 1 |
| Bauernfeind, A; Eberlein, E; Jungwirth, R; Schweighart, S | 1 |
| Chin, NX; Huang, HB; Klein, O; Neu, HC | 1 |
| Abe, T; Hagiwara, N; Iizuka, T; Kawashima, S; Kondo, Y; Kubota, K; Negishi, S; Tajima, T | 1 |
| Fujii, R; Meguro, H; Terashima, I | 1 |
| Niinou, K; Sato, H | 1 |
| Akita, H; Iwata, S; Sato, Y; Sunakawa, K; Yokota, T | 1 |
| Hatakeyama, K; Ishihara, T; Kawamura, K; Nakamura, H; Sano, T; Seo, K; Toyonaga, Y | 1 |
| Hayakawa, F; Kondo, M; Kuno, K; Ogawa, A; Okumura, A; Takahashi, H | 1 |
| Iwai, N; Miyazu, M; Nakamura, H; Taneda, Y; Watanabe, Y | 1 |
| Azuma, E; Ihara, T; Itoh, M; Kamiya, H; Kitamura, K; Sakurai, M | 1 |
| Aoki, S; Nishimura, T; Tabuki, K; Takagi, M | 1 |
| Higashino, H; Ishizaki, Y; Kino, M; Kobayashi, Y; Man, W; Takaya, J; Taniuchi, S | 1 |
| Haruta, T; Kobayashi, Y; Kuroki, S; Nikami, H; Okura, K | 2 |
| Kaino, Y; Kida, K; Matsuda, H | 1 |
| Arai, J; Fujieda, M; Hosokawa, T; Maeda, H; Morisawa, Y; Morita, H; Nagao, A; Shinohara, M; Takeda, K; Watanabe, S | 1 |
| Okamoto, T; Sekiguchi, T | 1 |
| Aramaki, M; Handa, S; Motohiro, T; Oda, K; Oki, S; Sakata, Y; Sasaki, H; Yamada, S; Yamashita, F; Yoshinaga, Y | 1 |
| Abe, T; Fujii, R; Meguro, H; Nakazawa, S; Niinou, K; Sato, H; Sunakawa, K; Tajima, T; Terashima, I; Yokota, T | 1 |
| Akita, H; Fujii, R; Iwai, N; Iwata, S; Kobayashi, Y; Kuno, K; Meguro, H; Nishimura, T; Sunakawa, K; Toyonaga, Y | 1 |
| Borner, K; Koeppe, P; Lode, H; Müller, HJ; Paulfeuerborn, W | 1 |
| Borner, E; Borner, K; Lode, H | 1 |
| Hayashi, R; Iizawa, Y; Imada, A; Iwahi, T; Okonogi, K; Yamazaki, T | 1 |
| Fujii, R; Fujiwara, T; Inui, T; Ishihara, T; Itoh, M; Iwai, N; Kamiya, H; Kawaoi, Y; Kawasaki, H; Kondoh, Y; Kuno, K; Meguro, H; Miyajima, Y; Nakamura, H; Nakayama, M; Niinou, K; Sakurai, M; Sato, Y; Suga, S; Sunakawa, K; Taniguchi, K; Terashima, I; Toyonaga, Y; Yokota, T; Yoshimura, K | 1 |
| Abe, T; Fujii, R; Fujita, K; Funamoto, N; Hashira, S; Inyaku, F; Kakuya, F; Kantake, M; Kawaoi, Y; Kondoh, Y; Maruyama, S; Meguro, H; Nagai, S; Nakazato, Y; Nishimura, S; Okuno, A; Sakata, H; Sugimori, S; Sugiura, M; Sunakawa, K; Tajima, T; Takeuchi, Y; Terashima, I; Yagisawa, M; Yoshimura, K | 1 |
| Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, Y; Tanaka, S | 1 |
| Abe, T; Fujii, R; Meguro, H; Tajima, T; Terashima, I | 1 |
| Okonogi, K; Tsuchimori, N; Yamazaki, T | 1 |
| Miyake, A; Okonogi, K | 1 |
| Okonogi, K; Tsuchimori, N | 1 |
| Hara, K; Kobayashi, H; Moritono, S | 1 |
| Higurashi, Y; Nakahara, K; Okuzumi, K; Yoneyama, A | 1 |
| Akita, H; Iwata, S; Kusumoto, Y; Sato, Y; Sunakawa, K; Yokota, T | 1 |
| Abe, T; Funamoto, N; Hashira, S; Kawaoi, Y; Kondoh, Y; Nagai, S; Nakazato, Y; Nishimura, S; Sugimori, S; Sugiura, M; Tajima, T; Yoshimura, K | 1 |
| Kantake, M; Meguro, H; Takeuchi, Y; Terashima, I | 1 |
| Fujimoto, T; Hashimoto, T; Hayashi, M; Kamizono, S; Matsuo, Y; Morita, J; Motohiro, T; Nagai, K; Sakata, Y; Takagishi, T; Toyota, A; Wada, M; Yoshinaga, Y | 1 |
| Fukuda, M; Hayashi, K; Kusumoto, T; Nakashita, S; Takayanagi, T; Tanaka, H; Tomimasu, K; Tsuji, Y; Yoshinaga, M | 1 |
| Awaya, Y; Fujiue, Y; Kodomari, Y; Kuwabara, M; Muroki, K; Shimizu, S; Watanabe, Y | 1 |
| Dohmen, K; Irie, K; Ishibashi, H; Miyamoto, Y; Onohara, S; Shimada, T; Shirahama, M | 1 |
| Horiike, S; Iwai, T; Kaneko, H; Kashima, K; Misawa, S; Nakazawa, N; Ohgawara, Y; Sasai, Y; Tamura, A; Taniwaki, M; Tsuda, S; Ueda, Y; Yokota, S | 1 |
| Kinoshita, S; Kumagai, S | 1 |
| Fujii, R; Hiramatsu, N; Hishikawa, T; Hujimaki, T; Kuwahara, M; Nagasaki, M; Sagara, Y; Sakurai, Y | 1 |
| Dan, K; Furuya, T; Harada, Y; Hirosawa, S; Ikeda, Y; Kawaguchi, M; Kawamata, N; Kawano, K; Kikuchi, M; Matsuoka, S; Murakami, H; Onozawa, Y; Oshimi, K; Sawanobori, M; Shirota, T; Suzuki, K; Takeuchi, J; Tomoyasu, S; Toyama, K; Tsuruoka, N; Uchida, Y; Wakasugi, K; Yaguchi, M; Yamada, T; Yamamoto, K | 1 |
| Asano, Y; Iriyama, J; Ishigo, S; Minakuchi, K | 1 |
| Aoki, K; Asano, S; Bessho, M; Fujita, A; Furusawa, S; Higashihara, M; Hirai, H; Hoshino, S; Hotta, T; Kitamura, K; Koike, M; Kuraishi, Y; Kurihara, I; Mizoguchi, H; Nagoshi, H; Nishimura, M; Nonaka, Y; Ohbayashi, Y; Omine, M; Oshimi, K; Ozawa, K; Suzuki, K; Takaku, F; Togawa, A; Urabe, A; Wakabayashi, Y | 1 |
| Kawano, C; Kirikae, T; Muroi, K; Ozawa, K; Yozhizawa, M | 1 |
| Arakawa, S; Fujii, A; Hazama, M; Imanishi, O; Ito, N; Ka, S; Kamidono, S; Kawabata, G; Kominami, M; Kondo, K; Maruyama, S; Matsui, T; Matsumoto, H; Matsumoto, O; Minayoshi, K; Mizuno, Y; Morisue, K; Nagata, H; Nakamura, I; Ohbe, S; Okamoto, Y; Shinozaki, M; Tanaka, H; Tanaka, K; Tsuji, T; Umezu, K; Yamashita, M; Yosiyuki, K | 1 |
| Iizawa, Y; Ishikawa, T; Miyake, A; Okonogi, K | 1 |
| Iizawa, Y; Ishikawa, T; Kamiyama, K; Matsunaga, N; Miyake, A; Okonogi, K; Tawada, H | 1 |
| Bessho, M; Endo, K; Fukuda, M; Kawai, N; Maesaki, S; Takinami, S; Tominaga, K; Yamazaki, T | 1 |
| Abe, T; Fukuoka, T; Inoue, H; Ohya, S | 1 |
| Akasaka, S; Inatomi, H; Kobayashi, T; Matsumoto, T; Muratani, T; Takahashi, K; Yamada, Y | 1 |
| Endo, H; Jinbo, K; Nishinari, C; Suzuki, Y; Tamura, C | 1 |
| Higashiyama, Y; Hirakata, Y; Kadota, JI; Kakeya, H; Kaneko, Y; Kohno, S; Kuroki, M; Miyazaki, Y; Ohi, H; Tomono, K; Yanagihara, K | 1 |
| Hamada, T; Kodama, H; Osaki, T; Ueta, E | 1 |
| Akiyama, K; Hiramatsu, N; Igari, J; Koyama, T; Oguri, T | 4 |
| Akiyama, K; Endo, H; Hiramatsu, N; Jinbo, K; Koyama, T; Nishinari, C; Suzuki, Y; Tamura, C | 2 |
| Akagi, S; Imamura, Y; Murakami, Y; Ohge, H; Sueda, T; Takesue, Y; Yokoyama, T | 1 |
| Hamada, K; Konishi, M; Maeda, K; Mikasa, K; Mori, K; Nakamura, T; Narita, N; Takahashi, K; Yoshimoto, E | 1 |
| Asari, S; Horikawa, M; Iwatani, Y; Nishi, I; Sunada, A; Toyokawa, M; Tsukamoto, H; Ueda, A | 1 |
| Akiyama, K; Endo, H; Hiramatsu, N; Koyama, T; Nishinari, C; Suzuki, Y | 2 |
| Ando, H; Katsuno, S; Ochiai, K; Ohta, M; Seo, T; Shinohara, T | 1 |
| Fujii, N; Fukuda, S; Hara, M; Harada, M; Ikeda, K; Imajoh, K; Ishimaru, F; Kojima, K; Miyata, A; Nakase, K; Nawa, Y; Saito, T; Shinagawa, K; Sunami, K; Takeuchi, M; Tanimoto, M; Teshima, T; Yano, T | 1 |
| Hoshinaga, K; Ishikawa, K; Miyakawa, S; Naide, Y; Shiroki, R; Tanaka, T | 1 |
| Kataoka, D; Tanaka, Y | 1 |
| Furuta, I; Kitahashi, T | 1 |
| Hasui, T; Ishiyama, S; Itoshima, T; Kajitani, N; Shiode, J; Takada, S; Yamamoto, K | 1 |
| Fukushima, Y; Hiraoka, N; Morimoto, T; Morita, S; Nishisho, I; Nomura, T; Shibata, N | 1 |
| Araki-Sasaki, K; Asari, S; Matsumoto, K; Mutoh, K; Nishi, I; Takatsuka, H; Tanihara, H; Yonemura, N | 1 |
| Abe, H; Kohshi, K; Mizoguchi, Y; Shimokobe, M | 1 |
| Ookubo, H | 1 |
| Arakawa, S; Deguchi, T; Egashira, T; Fujime, M; Fujita, K; Fukuhara, Y; Furuya, N; Hirakata, Y; Hirose, T; Igari, J; Imafuku, Y; Ishibashi, K; Ishihara, S; Kamidono, S; Kitamura, M; Kobayashi, Y; Kohno, S; Kondo, A; Konishi, T; Kumamoto, Y; Kumon, H; Kunishima, Y; Matsuda, J; Matsuda, S; Matsukawa, M; Matsumoto, T; Monden, K; Murai, M; Muratani, T; Naito, S; Nakano, M; Oguri, T; Oka, T; Ooe, H; Sato, S; Shigeta, S; Suzutani, T; Tsukamoto, T; Uchida, H; Watanabe, K; Yamaguchi, K; Yamaguti, O; Yoshida, H | 1 |
| Ikawa, K; Ikeda, K; Matsuda, S; Morikawa, N; Ohge, H; Sueda, T; Takesue, Y | 1 |
| Ikawa, K; Ikeda, K; Kuribayashi, M; Morikawa, N; Nomura, K; Taniwaki, M | 1 |
| Fujimoto, Y; Fujita, N; Ikawa, K; Ikeda, K; Kanbayashi, Y; Komori, T; Matsumoto, Y; Morikawa, N; Nomura, K; Shimazaki, C; Shimizu, D; Shimura, K; Taniguchi, K; Taniwaki, M | 1 |
| Ikawa, K; Ikeda, K; Morikawa, N; Nomura, K; Ohge, H; Sueda, T; Taniwaki, M | 1 |
| Ikawa, K; Ikeda, K; Morikawa, N; Ohge, H; Sueda, T | 2 |
| Ikawa, K; Ikeda, K; Mikamo, H; Morikawa, N; Tamaya, T | 1 |
| Iguchi, A; Kaneda, M; Kobayashi, K; Kobayashi, R; Sato, T; Yasuda, K | 1 |
| Ikawa, K; Ikeda, K; Kobayashi, R; Kozumi, T; Morikawa, N | 1 |
| Hu, CQ; Liu, SY; Zhang, DS | 1 |
| Dazai, M; Kobayashi, Y; Kubo, K; Miyagishima, T; Oda, H; Ohnishi, S; Onishi, R; Ono, M; Suzuki, M; Tada, K; Takahashi, S; Takahashi, T; Yamamoto, J | 1 |
| Ariga, T; Cho, Y; Ichikawa, M; Iguchi, A; Kaneda, M; Ohshima, J; Suzuki, D | 1 |
| Danno, K; Fujimoto, N; Tanaka, T; Uenishi, T; Wakabayashi, M | 1 |
| Hu, CQ; Li, YP; Liu, SY | 1 |
| Guo, WW; Liang, MZ; Miao, J; Nan, F; Qin, YP; Shen, Q; Wang, L; Wang, Y; Xiang, J; Yu, Q | 1 |
| Hino, R; Kabashima-Kubo, R; Nakamura, M; Sawada, Y | 1 |
| Hashimoto, Y; Kondo, N; Murakami, Y; Nakagawa, N; Ohge, H; Sudo, T; Sueda, T; Uemura, K | 1 |
| Azuma, H; Kobayashi, R; Sano, H; Sarashina, T; Suzuki, D; Toriumi, N; Yoshida, M | 1 |
| Akiyama, N; Fukushima, T; Hatanaka, K; Hino, M; Kanamaru, A; Masaoka, T; Nakagawa, Y; Nakane, T; Ohyashiki, K; Takahashi, T; Tamaki, T; Tamura, K; Tanimoto, M; Tatsumi, Y; Urabe, A; Yoshida, I | 1 |
| Hu, XJ; Liu, J; Shentu, JZ; Wu, GL; Wu, LH; Zhou, HL; Zhu, MX | 1 |
| Cielecka-Piontek, J; Garbacki, P; Paczkowska, M; Skibiński, R; Talaczyńska, A; Zalewski, P | 1 |
| Cielecka-Piontek, J; Garbacki, P; Jelińska, A; Paczkowska, M; Skibiński, R; Talaczyńska, A; Zalewski, P | 1 |
| Srinivas, NR | 1 |
| Honda, T; Horiuchi, K; Kasuga, E; Matsumoto, T; Natori, T; Negishi, T; Saito, S; Sugano, M; Takehara, K | 1 |
| Miyamura, K; Mori, K; Mukoyama, N; Nakashima, M; Noda, Y; Yoshimi, A | 1 |
| Morisawa, Y; Sasahara, T; Suzuki, J; Toshima, M | 1 |
| Imashioya, T; Imuta, N; Kawano, Y; Kirishima, M; Kodama, Y; Koriyama, T; Nakagawa, S; Nishi, J; Nishikawa, T; Okamoto, Y; Ooka, T; Tanabe, T; Tanimoto, A | 1 |
| Fujii, K; Hishiki, H; Hotta, M; Ishiwada, N; Murata, S; Ohkusu, M; Takeuchi, N | 1 |
| Esumi, S; Higashionna, T; Kitamura, Y; Murakawa, K; Sendo, T; Ushio, S | 1 |
12 review(s) available for cephalosporin c and dactinomycin
| Article | Year |
|---|---|
Production of the same antibiotics by members of different genera of microorganisms.
Topics: Amino Acids; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cephalosporins; Chemical Phenomena; Chemistry; Dactinomycin; Erythromycin; Fungi; Nucleosides; Penicillins; Phenazines; Phenols; Prodigiosin; Pyrones; Pyrrolidinones; Quinones; Species Specificity; Steroids; Triazines | 1975 |
Effect of primary metabolites on secondary metabolism.
Topics: Adenosine Triphosphate; Amino Acids; Anti-Bacterial Agents; Bacteria; Carbohydrate Metabolism; Carbon; Cephalosporins; Dactinomycin; Enzyme Repression; Ergolines; Fungi; Kanamycin; Nitrogen; Penicillins | 1977 |
Antibiotic tolerance in producer organisms.
Topics: Anisomycin; Anti-Bacterial Agents; Antifungal Agents; Antimycin A; Bacteria; Cephalosporins; Chloramphenicol; Cycloheximide; Dactinomycin; Erythromycin; Fungi; Penicillin Resistance; Penicillins; Species Specificity; Streptomycin; Tenuazonic Acid; Tetracyclines; Thiostrepton | 1979 |
Modes of action of antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Proteins; Cell Membrane; Cell Membrane Permeability; Cell Wall; Cephalosporins; Chloramphenicol; Dactinomycin; DNA, Bacterial; Escherichia coli; Mitomycins; Penicillins; Polymyxins; Pseudomonas; Ribosomes; RNA, Bacterial; Spheroplasts; Streptomycin | 1977 |
Biosynthesis of peptide antibiotics.
Topics: Anti-Bacterial Agents; Aspergillus; Bacillus; Bacitracin; Cephalosporins; Chemical Phenomena; Chemistry; Dactinomycin; Methods; Penicillanic Acid; Penicillin G; Penicillins; Penicillium; Peptide Biosynthesis; Peptides, Cyclic; Piperazines; Polymyxins; Streptococcus; Streptomyces; Thiazines; Tyrothricin; Valinomycin | 1971 |
[Biosynthesis of peptide antibiotics].
Topics: Acremonium; Alkaloids; Amino Acid Sequence; Anti-Bacterial Agents; Bacillus subtilis; Bacitracin; Cephalosporins; Cyclization; Dactinomycin; Disulfides; Fungi; Hydrolysis; Indoles; Molecular Weight; Nisin; Oligopeptides; Penicillin Resistance; Penicillins; Penicillium chrysogenum; Peptide Biosynthesis; Piperazines; Polymyxins; Streptomyces; Tyrothricin; Valinomycin | 1972 |
Biosynthesis of small peptides.
Topics: Actinomyces; Aminoacylation; Anti-Bacterial Agents; Aspergillus; Bacillus; Bacitracin; Carbon Radioisotopes; Cephalosporins; Dactinomycin; Ergot Alkaloids; Gramicidin; Molecular Weight; Oligopeptides; Penicillins; Peptide Biosynthesis; Peptide Synthases; Peptides, Cyclic; Peptidoglycan; Polymyxins; Quinoxalines | 1974 |
The application of microbial enzymes which inactivate antibiotics: a review.
Topics: Amidohydrolases; Anti-Bacterial Agents; Bacteria; Cephalosporins; Chemical Phenomena; Chemistry; Chloramphenicol; Dactinomycin; Enzymes; Penicillinase; Penicillins; Streptomycin | 1969 |
Successes and failures in the search for antibiotics.
Topics: Acremonium; Actinomycetales; Amebicides; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antifungal Agents; Antineoplastic Agents; Antiviral Agents; Aspergillus; Bacillus subtilis; Cephalosporins; Chloramphenicol; Dactinomycin; Daunorubicin; Erythromycin; Escherichia coli; Fusidic Acid; Griseofulvin; Neomycin; Nystatin; Penicillins; Penicillium; Polymyxins; Pseudomonas aeruginosa; Quackery; Streptomycin; Tetracycline; Tyrothricin | 1969 |
The mechanism of action of some antibacterial agents.
Topics: Amino Acids; Anti-Bacterial Agents; Bacitracin; Bacteria; Cell Membrane; Cell Wall; Cephalosporins; Chloramphenicol; Cycloserine; Dactinomycin; Edetic Acid; Lysostaphin; Metals; Mitomycins; Mucoproteins; Muramidase; Nalidixic Acid; Novobiocin; Nucleic Acids; Penicillins; Peptide Biosynthesis; Phenols; Polymyxins; Puromycin; Quaternary Ammonium Compounds; Ristocetin; Streptomycin; Tetracycline; Vancomycin | 1969 |
[Possibility of drug design of beta-lactam antibiotics effective for multiresistant gram-positive pathogens].
Topics: Animals; Anti-Bacterial Agents; Bacterial Adhesion; beta-Lactam Resistance; Cefozopran; Cephalosporins; Digestive System; Drug Design; Drug Resistance, Multiple; Gram-Positive Bacteria; Mice | 1997 |
Peripherally inserted central catheter-related bloodstream infection due to Tsukamurella pulmonis: a case report and literature review.
Topics: Acquired Immunodeficiency Syndrome; Actinobacteria; Administration, Intravenous; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Catheter-Related Infections; Catheterization, Peripheral; Cefozopran; Cephalosporins; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged | 2017 |
37 trial(s) available for cephalosporin c and dactinomycin
| Article | Year |
|---|---|
[Pharmacokinetic, bacteriological and clinical studies on cefozopran in children].
Topics: Bacteria; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Infusions, Intravenous; Injections, Intravenous; Male | 1994 |
[Clinical evaluation of cefozopran in the pediatric field].
Topics: Acute Disease; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male | 1994 |
[Studies on cefozopran in the pediatric field].
Topics: Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Infusions, Intravenous; Male | 1994 |
[Pharmacokinetic and clinical studies on cefozopran in pediatrics].
Topics: Adolescent; Bacterial Infections; Blood Coagulation; Cefozopran; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Infusions, Intravenous; Injections, Intravenous; Male | 1994 |
[Pharmacokinetic and clinical evaluation of cefozopran in the pediatric field].
Topics: Adolescent; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Infusions, Intravenous; Injections, Intravenous; Male | 1994 |
[Pharmacokinetic and clinical studies of cefozopran in the field of pediatrics].
Topics: Cefozopran; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Injections, Intravenous; Male; Pneumonia; Urinary Tract Infections | 1994 |
[Pharmacokinetic and clinical evaluation of cefozopran in the pediatric field].
Topics: Acute Disease; Adolescent; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Injections, Intravenous; Male | 1994 |
[Pharmacokinetic and clinical studies of cefozopran in the field of pediatrics].
Topics: Adolescent; Bacteria; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Male | 1994 |
[Bacteriological and clinical studies on cefozopran in pediatric field].
Topics: Bacteria; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Male | 1994 |
[Clinical evaluation of a new parenteral cephem, cefozopran, in children].
Topics: Bacteria; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Infusions, Intravenous; Male | 1994 |
[Clinical studies on cefozopran in pediatrics].
Topics: Adolescent; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Injections, Intravenous; Male | 1994 |
[Pharmacokinetic and clinical studies on cefozopran in the field of pediatrics].
Topics: Bacteria; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Injections, Intravenous; Male | 1994 |
[Clinical studies on cefozopran in pediatrics].
Topics: Adolescent; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Infusions, Intravenous; Male | 1994 |
[Clinical studies on cefozopran in pediatrics].
Topics: Bacteria; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Infusions, Intravenous; Injections, Intravenous; Male | 1994 |
[Pharmacokinetic, bacteriological and clinical studies on cefozopran in the pediatric field].
Topics: Bacteria; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Infusions, Intravenous; Injections, Intravenous; Male | 1994 |
[Pharmacokinetic and clinical studies with cefozopran in the pediatric field. Pediatric Study Group of Cefozopran].
Topics: Adolescent; Bacteria; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Diarrhea; Drug Eruptions; Female; Half-Life; Humans; Infant; Japan; Male; Meningitis, Bacterial; Respiratory Tract Infections; Urinary Tract Infections | 1994 |
Comparative pharmacokinetics and serum bactericidal activities of SCE-2787 and ceftazidime.
Topics: Adult; Bacteria; Cefozopran; Ceftazidime; Cephalosporins; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Protein Binding; Serum Bactericidal Test | 1993 |
[Optimum dose study of cefozopran in the pediatric field].
Topics: Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Pneumonia, Bacterial | 1996 |
[Pharmacokinetic, bacteriological and clinical studies on cefozopran in neonates and premature infants. A study of cefozopran in the perinatal co-research group].
Topics: Bacterial Infections; Cefozopran; Cephalosporins; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Male | 1996 |
[Fundamental and clinical evaluation of cefozopran in low birth weight infants and neonates].
Topics: Bacterial Infections; Cefozopran; Cephalosporins; Female; Half-Life; Humans; Infant, Low Birth Weight; Infant, Newborn; Infusions, Intravenous; Injections, Intravenous; Male | 1997 |
[Pharmacokinetic, bacteriological and clinical studies on cefozopran in neonates].
Topics: Bacterial Infections; Cefozopran; Cephalosporins; Female; Half-Life; Humans; Infant, Newborn; Infusions, Intravenous; Injections, Intravenous; Male | 1997 |
[Pharmacokinetic, bacteriological and clinical studies on cefozopran in neonates].
Topics: Bacterial Infections; Cefozopran; Cephalosporins; Female; Half-Life; Humans; Infant, Newborn; Infusions, Intravenous; Injections, Intravenous; Male | 1997 |
[Pharmacokinetic and clinical evaluation of cefozopran in premature and newborn patients].
Topics: Bacterial Infections; Cefozopran; Cephalosporins; Female; Half-Life; Humans; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Injections, Intravenous; Male | 1997 |
[Pharmacokinetic and clinical evaluation of cefozopran in newborn patients].
Topics: Bacterial Infections; Cefozopran; Cephalosporins; Female; Half-Life; Humans; Infant, Newborn; Injections, Intravenous; Male | 1997 |
[Clinical evaluation of cefozopran for infections associated with hematological malignancies].
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Bacterial Infections; Bronchitis; Cefozopran; Cephalosporins; Female; Granulocytes; Hodgkin Disease; Humans; Leukemia; Leukemia, Myeloid, Acute; Leukemia, T-Cell; Leukocyte Count; Lymphoma; Male; Middle Aged; Multiple Myeloma; Peritonitis; Pneumonia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sepsis; Severity of Illness Index | 1998 |
[Clinical effects of combination therapy with cefozopran and tobramycin for severe infections in patients with hematologic diseases].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefozopran; Cephalosporins; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Infections; Male; Middle Aged; Sepsis; Tobramycin | 1999 |
[Efficacy and safety of cefozopran (CZOP) monotherapy and combination therapy with CZOP and amikacin (AMK) for infections accompanying hematological diseases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefozopran; Cephalosporins; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Pneumonia, Bacterial; Sepsis | 2000 |
[A comparative study on the clinical utility of cefozopran and cefpirome against complicated urinary tract infections].
Topics: Adult; Aged; Aged, 80 and over; Cefozopran; Cefpirome; Cephalosporins; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Treatment Outcome; Urinary Tract Infections | 2000 |
[Clinical effects of combination therapy with cefozopran and amikacin for infections in patients with hematological disorders].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefozopran; Cephalosporins; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Opportunistic Infections; Treatment Outcome | 2001 |
[Clinical evaluation of cefozopran as treatment for febrile neutropenia].
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefozopran; Cephalosporins; Female; Fever; Humans; Leukemia; Male; Middle Aged; Neutropenia | 2004 |
Optimized dosage and frequency of cefozopran for patients with febrile neutropenia based on population pharmacokinetic and pharmacodynamic analysis.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefozopran; Cephalosporins; Female; Fever; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Monte Carlo Method; Neutropenia; Plasma | 2008 |
A prospective, randomized study comparing cefozopran with piperacillin-tazobactam plus ceftazidime as empirical therapy for febrile neutropenia in children with hematological disorders.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefozopran; Ceftazidime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Infant; Infant, Newborn; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prognosis; Prospective Studies; Survival Rate | 2008 |
Piperacillin/tazobactam versus cefozopran for the empirical treatment of pediatric cancer patients with febrile neutropenia.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2011 |
[Pharmacokinetics of injected cefozopran hydrochloride in healthy volunteers].
Topics: Adult; Anti-Bacterial Agents; Cefozopran; Cephalosporins; Chromatography, High Pressure Liquid; Female; Humans; Infusions, Intravenous; Male; Young Adult | 2012 |
A randomized trial of cefozopran versus cefepime as empirical antibiotic treatment of febrile neutropenia in pediatric cancer patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefepime; Cefozopran; Cephalosporins; Child; Child, Preschool; Febrile Neutropenia; Female; Humans; Infant; Infant, Newborn; Male; Neoplasms | 2014 |
Cefozopran, meropenem, or imipenem-cilastatin compared with cefepime as empirical therapy in febrile neutropenic adult patients: A multicenter prospective randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cefozopran; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Male; Meropenem; Middle Aged; Prospective Studies; Thienamycins; Young Adult | 2015 |
Pharmacokinetics of cefozopran by single and multiple intravenous infusions in healthy Chinese volunteers.
Topics: Adult; Anti-Bacterial Agents; Area Under Curve; Asian People; Cefozopran; Cephalosporins; Chromatography, High Pressure Liquid; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Infusions, Intravenous; Male; Tandem Mass Spectrometry; Tissue Distribution; Young Adult | 2015 |
76 other study(ies) available for cephalosporin c and dactinomycin
| Article | Year |
|---|---|
Effect of antibiotics on the growth of various strains of Mycoplasma.
Topics: Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Chlortetracycline; Culture Techniques; Cycloheximide; Dactinomycin; Erythromycin; Kanamycin; Leucomycins; Lincomycin; Mitomycins; Mycoplasma; Oxytetracycline; Penicillins; Puromycin; Streptomycin; Tetracycline | 1967 |
Protein synthesis by long-lived messenger ribonucleic acid in bacteria.
Topics: Amino Acids; Bacillus; Bacillus megaterium; Carbon Isotopes; Cephalosporins; Dactinomycin; Penicillinase; Protein Biosynthesis; RNA, Bacterial; RNA, Messenger | 1966 |
Lifetime of messenger ribonucleic acid for penicillinase synthesis in several strains of bacilli.
Topics: Bacillus; Bacillus cereus; Cephalosporins; Dactinomycin; Enzyme Induction; Genetics, Microbial; Mutation; Penicillinase; RNA, Bacterial; RNA, Messenger; Stimulation, Chemical; Time Factors | 1968 |
The stability and cell content of penicillinase messenger RNA in Bacillus licheniformis.
Topics: Bacillus; Bacterial Proteins; Carbon Isotopes; Cephalosporins; Dactinomycin; Penicillin G; Penicillinase; Rifampin; RNA, Bacterial; RNA, Messenger | 1969 |
METABOLIC CONTROL OF PENICILLINASE BIOSYNTHESIS IN BACILLUS CEREUS.
Topics: Azaguanine; Bacillus cereus; Cephalosporins; Cytosine; Dactinomycin; Enzyme Inhibitors; Mercury; Penicillanic Acid; Penicillin G; Penicillinase; Penicillins; Pharmacology; Proteins; Research; RNA; RNA, Messenger; Thymine; Uracil | 1964 |
Comparative pharmacokinetics of SCE-2787 and related antibiotics in experimental animals.
Topics: Animals; Anti-Bacterial Agents; Biliary Tract; Blood Proteins; Cefozopran; Cefpirome; Ceftazidime; Cephalosporins; Dogs; Drug Administration Schedule; Female; Macaca fascicularis; Male; Mice; Mice, Inbred ICR; Protein Binding; Rabbits; Rats; Rats, Sprague-Dawley; Species Specificity | 1992 |
In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrum.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Cefozopran; Cephalosporins; Gram-Negative Bacteria; Mice; Microbial Sensitivity Tests | 1992 |
Studies on condensed-heterocyclic azolium cephalosporins. IV. Synthesis and antibacterial activity of 7 beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)- alkoxyiminoacetamido]-3-(condensed-heterocyclic azolium)methyl cephalosporins including SCE-2787.
Topics: Cefozopran; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Heterocyclic Compounds; Microbial Sensitivity Tests; Structure-Activity Relationship | 1992 |
Antibacterial properties of SCE-2787, a new cephem antibiotic.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carrier Proteins; Cefozopran; Cefpirome; Ceftazidime; Cephalosporins; Escherichia coli; Hexosyltransferases; Microbial Sensitivity Tests; Microscopy; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Protein Binding; Pseudomonas aeruginosa; Staphylococcus aureus | 1992 |
In vitro activity and stability against novel beta-lactamases of investigational beta-lactams (cefepime, cefpirome, flomoxef, SCE2787 and piperacillin plus tazobactam) in comparison with established compounds (cefotaxime, latamoxef and piperacillin).
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cefozopran; Cefpirome; Cephalosporins; Drug Stability; Enterobacteriaceae; Hydrolysis; Microbial Sensitivity Tests; Moxalactam; Penicillanic Acid; Piperacillin; Tazobactam | 1991 |
In vitro activity of SCE-2787, a new cephalosporin with potent activity against Pseudomonas aeruginosa and members of the family Enterobacteriaceae.
Topics: beta-Lactamases; Cefozopran; Cephalosporins; Drug Stability; Enterobacteriaceae; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1994 |
[Criteria for clinical evaluation of antibiotics in pediatrics. The purpose and process for establishing the criteria].
Topics: Bacterial Infections; Cefozopran; Cephalosporins; Child; Clinical Trials as Topic; Humans; Pediatrics | 1993 |
Determination of a new cephalosporin, SCE-2787, in serum and urine by high-performance liquid chromatography.
Topics: beta-Lactamases; Biological Assay; Cefozopran; Cephalosporins; Chromatography, High Pressure Liquid; Escherichia coli; Humans; Hydrolysis; Spectrophotometry, Ultraviolet | 1993 |
Therapeutic effect of cefozopran (SCE-2787), a new parenteral cephalosporin, against experimental infections in mice.
Topics: Animals; Bacterial Infections; Cefozopran; Cephalosporins; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred CBA; Mice, Inbred ICR; Muscular Diseases; Pseudomonas Infections; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections | 1993 |
[Transferability of cefozopran to cerebrospinal fluid in rabbits with meningitis caused by Staphylococcus aureus].
Topics: Animals; Biological Transport; Cefozopran; Cephalosporins; Half-Life; Meningitis, Bacterial; Rabbits; Staphylococcal Infections; Tissue Distribution | 1996 |
[Antimicrobial activities of cefozopran against Streptococcus pneumoniae from children].
Topics: Anti-Bacterial Agents; Cefozopran; Ceftazidime; Cephalosporins; Child; Drug Resistance, Microbial; Erythromycin; Humans; Penicillin G; Streptococcus pneumoniae | 1996 |
Pharmacokinetics and clinical effects of cefozopran in pediatric patients.
Topics: Bacteria; Bacterial Infections; Cefozopran; Cephalosporins; Child; Humans | 1996 |
Therapeutic effects of cefozopran against experimental mixed urinary tract infection with Enterococcus faecalis and Pseudomonas aeruginosa in mice.
Topics: Ampicillin; Animals; Cefozopran; Ceftazidime; Cephalosporins; Cilastatin; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Imipenem; Mice; Mice, Inbred CBA; Ofloxacin; Pseudomonas Infections; Urinary Tract Infections | 1997 |
Penicillin-binding protein 5 as an inhibitory target of cefozopran in Enterococcus faecalis.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carrier Proteins; Cefozopran; Cephaloridine; Cephalosporins; Enterococcus faecalis; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Protein Binding | 1996 |
[Significant role of new cephem antibiotics: Focused on cefozopran].
Topics: Animals; Bacterial Infections; Cefozopran; Cephalosporins; Humans | 1997 |
[The in vitro antibacterial activity of cefozopran against clinically isolated bacteria].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefozopran; Cephalosporins; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Humans; Vancomycin | 1997 |
[The antimicrobial susceptibilities and serotypes of Pseudomonas aeruginosa isolated from sputum].
Topics: Anti-Bacterial Agents; Aztreonam; Carbapenems; Cefozopran; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Meropenem; Monobactams; Penicillins; Piperacillin; Pseudomonas aeruginosa; Serotyping; Sputum; Thienamycins | 1998 |
Obstructive jaundice due to multiple hepatic abscesses.
Topics: Bacteroides Infections; Cefozopran; Cephalosporins; Cholestasis; Drainage; Escherichia coli Infections; Humans; Infusions, Intravenous; Klebsiella Infections; Liver Abscess; Male; Middle Aged | 1998 |
[Antimicrobial activity of carbapenem antibiotics against gram-negative bacilli].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Carbapenems; Cefozopran; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Imipenem; Meropenem; Monobactams; Norfloxacin; Tetracycline; Thienamycins | 1998 |
[Pharmacokinetic analysis of cefozopran in neonatal infections--population pharmacokinetics using nonmem].
Topics: Cefozopran; Cephalosporins; Female; Humans; Infant, Newborn; Infections; Male; Statistics as Topic | 1999 |
[Bacteriological and clinical break points: evaluation of the usefulness of cefozopran based on MIC].
Topics: Cefozopran; Cephalosporins; Citrobacter; Enterobacter; Enterococcus; Escherichia coli; Humans; Klebsiella; Methicillin Resistance; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa; Serratia; Staphylococcus aureus | 1999 |
Filamented Pseudomonas aeruginosa and a markedly high level of endotoxin in cerebrospinal fluid.
Topics: Adult; Cefozopran; Cephalosporins; Cerebrospinal Fluid; Endotoxins; Fatal Outcome; Humans; Japan; Male; Meningitis, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections | 2000 |
Studies on anti-MRSA parenteral cephalosporins. I. Synthesis and antibacterial activity of 7beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)- hydroxyiminoacetamido]-3-(substituted imidaz.
Topics: Animals; Cefozopran; Cephalosporins; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Oximes; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship | 2000 |
Studies on anti-MRSA parenteral cephalosporins. II. Synthesis and antibacterial activity of 7beta-[2-(5-amino-1,2,4- thiadiazol-3-yl)-2(Z)-alkoxyiminoacetamido]-3-(substituted imidaz.
Topics: Animals; Cefozopran; Cephalosporins; Gram-Negative Bacteria; Magnetic Resonance Spectroscopy; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship | 2000 |
[In vitro and in vivo activities of panipenem against penicillin-resistant Streptococcus pneumoniae].
Topics: Ampicillin; Animals; beta-Alanine; Cefozopran; Ceftriaxone; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Resistance; Imipenem; Male; Meropenem; Mice; Mice, Inbred Strains; Penicillin Resistance; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2001 |
Outbreak of cefozopran (penicillin, oral cephems, and aztreonam)-resistant Neisseria gonorrhoeae in Japan.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Cefozopran; Cephalosporins; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple; Female; Gonorrhea; Humans; Japan; Male; Microbial Sensitivity Tests; Monobactams; Neisseria gonorrhoeae; Penicillins; Polymorphism, Restriction Fragment Length | 2001 |
[Antimicrobial activities of carbapenems and fourth generation cephems against clinically isolated strains].
Topics: Bacteria; Carbapenems; Cefepime; Cefozopran; Cephalosporins; Imipenem; Meropenem; Thienamycins | 2001 |
Effects of parenterally administered ciprofloxacin in a murine model of pulmonary Pseudomonas aeruginosa infection mimicking ventilator-associated pneumonia.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Cefozopran; Cephalosporins; Cilastatin; Ciprofloxacin; Disease Models, Animal; Imipenem; Infusions, Parenteral; Male; Mice; Pneumonia, Bacterial; Protease Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Respiration, Artificial; Thienamycins | 2001 |
The excretion of cephem antibiotics into saliva is inversely associated with their plasma protein-binding activities.
Topics: Adult; Animals; Area Under Curve; Cefotaxime; Cefozopran; Ceftizoxime; Cephalosporins; Chromatography, High Pressure Liquid; Diffusion; Female; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Kinetics; Male; Perfusion; Protein Binding; Rats; Rats, Sprague-Dawley; Saliva; Statistics, Nonparametric | 2002 |
[Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria].
Topics: Cefozopran; Cephalosporins; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacteria; Peptostreptococcus; Product Surveillance, Postmarketing; Streptococcus | 2002 |
[Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
Topics: Acinetobacter; Cefozopran; Cephalosporins; Citrobacter; Drug Resistance, Bacterial; Enterobacter; Escherichia coli; Gram-Negative Bacteria; Haemophilus influenzae; Klebsiella; Microbial Sensitivity Tests; Moraxella catarrhalis; Morganella; Product Surveillance, Postmarketing; Proteus; Providencia; Pseudomonas; Serratia | 2002 |
[Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2000--I. Gram-positive bacteria].
Topics: Carbapenems; Cefozopran; Cephalosporins; Drug Resistance, Bacterial; Gram-Positive Bacteria; Penicillins; Time Factors | 2002 |
[Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2000--II. Gram-negative bacteria].
Topics: Carbapenems; Cefozopran; Cephalosporins; Drug Resistance, Bacterial; Gram-Negative Bacteria; Time Factors | 2002 |
Changes in the intestinal flora after the administration of prophylactic antibiotics to patients undergoing a gastrectomy.
Topics: Adult; Aged; Antibiotic Prophylaxis; Bacteria; Cefazolin; Cefozopran; Cephalosporins; Digestive System; Drug Resistance; Female; Gastrectomy; Humans; Infusions, Intravenous; Male; Middle Aged; Population Dynamics; Preoperative Care | 2002 |
[A case of AIDS-associated Haemophilus influenzae pneumonia with diffuse reticulonodular shadows].
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Cefozopran; Cephalosporins; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Pneumonia | 2002 |
In vitro combined effects of cefozopran/teicoplanin and cefozopran/vancomycin on methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefozopran; Cephalosporins; Drug Therapy, Combination; In Vitro Techniques; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Penicillins; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2003 |
[Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2001--I. Gram-positive bacteria].
Topics: Cefepime; Cefozopran; Cephalosporins; Gram-Positive Bacteria; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Staphylococcus aureus | 2003 |
[Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2001--II. Gram-negative bacteria].
Topics: Cefepime; Cefoperazone; Cefozopran; Cefpirome; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Gram-Negative Bacteria; Humans; Moraxella | 2003 |
A case of retroperitoneal abscess caused by Salmonella Oranienburg.
Topics: Abscess; Animals; Cefozopran; Cephalosporins; Child; Combined Modality Therapy; Decapodiformes; Disease Outbreaks; Equipment Contamination; Female; Food Contamination; Food Handling; Food Microbiology; Humans; Japan; Retroperitoneal Space; Salmonella; Salmonella Food Poisoning; Seafood; Species Specificity | 2003 |
[Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria].
Topics: Carbapenems; Cefozopran; Cephalosporins; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Penicillins; Product Surveillance, Postmarketing; Time Factors | 2003 |
[Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
Topics: Carbapenems; Cefozopran; Cephalosporins; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Monobactams; Penicillins; Product Surveillance, Postmarketing; Time Factors | 2003 |
[The trend and susceptibility to antibacterial agents of enterococcus species from urinary tract infections].
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Cefozopran; Cefpirome; Cephalosporins; Cilastatin; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Humans; Imipenem; Microbial Sensitivity Tests; Urinary Tract Infections | 2004 |
The combination of aztreonam and cefozopran against Stenotrophomonas maltophilia.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamase Inhibitors; Cefozopran; Cephalosporins; Humans; Microbial Sensitivity Tests; Stenotrophomonas maltophilia | 2004 |
Development and validation of a MEKC method for the direct determination of cefozopran in human serum.
Topics: Cefozopran; Cephalosporins; Chromatography, Micellar Electrokinetic Capillary; Humans; Serum | 2004 |
[Hepatic portal venous gas--a report of two cases successfully treated with conservative management].
Topics: Aged; Cefozopran; Cephalosporins; Clindamycin; Colitis; Colonic Diseases; Drug Therapy, Combination; Embolism, Air; Female; Gabexate; Gastrointestinal Hemorrhage; Humans; Ileitis; Meropenem; Portal Vein; Thienamycins; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2004 |
The significance of the intraoperative repeated dosing of antimicrobials for preventing surgical wound infection in colorectal surgery.
Topics: Aged; Antibiotic Prophylaxis; Cefazolin; Cefmetazole; Cefotiam; Cefozopran; Cephalosporins; Colorectal Neoplasms; Female; Humans; Intraoperative Care; Logistic Models; Male; Middle Aged; Retrospective Studies; Risk Factors; Statistics, Nonparametric; Surgical Wound Infection | 2005 |
Characteristics of Pseudomonas corneal infection related to orthokeratology.
Topics: Administration, Topical; Adolescent; Anti-Bacterial Agents; Cefmenoxime; Cefozopran; Cephalosporins; Contact Lenses; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections | 2005 |
Successful treatment of cervical spinal epidural abscess by combined hyperbaric oxygenation.
Topics: Anti-Bacterial Agents; Cefozopran; Cephalosporins; Combined Modality Therapy; Epidural Abscess; Humans; Hyperbaric Oxygenation; Magnetic Resonance Imaging; Male; Meningitis, Bacterial; Middle Aged; Neck; Spinal Cord Compression | 2005 |
[Outline of the drug use result survey of Firstcin (cefozopran hydrochloride) as part of postmarketing surveillance in Japan].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Data Collection; Female; Humans; Infant; Injections; Japan; Male; Middle Aged; Product Surveillance, Postmarketing | 2005 |
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Topics: Aminoglycosides; Ampicillin; Anti-Infective Agents; Aztreonam; Cefixime; Cefozopran; Cefpirome; Cefpodoxime; Ceftizoxime; Cephalosporins; Dibekacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Serratia marcescens; Staphylococcus aureus; Thienamycins; Urinary Tract Infections; Vancomycin | 2006 |
Peritoneal penetration and pharmacodynamic exposure of intravenous cefozopran in abdominal surgery patients.
Topics: Abdomen; Adult; Anti-Bacterial Agents; Area Under Curve; Ascitic Fluid; Blood Chemical Analysis; Cefozopran; Cephalosporins; Computer Simulation; Enterobacter; Escherichia coli; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Monte Carlo Method; Pseudomonas aeruginosa; Staphylococcus aureus; Time Factors; Tissue Distribution | 2007 |
Real-time therapeutic drug monitoring of cefozopran in plasma using high-performance liquid chromatography with ultraviolet detection.
Topics: Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Case-Control Studies; Cefozopran; Cephalosporins; Chromatography, High Pressure Liquid; Creatinine; Drug Monitoring; Hemofiltration; Humans; Metabolic Clearance Rate; Microbial Sensitivity Tests; Middle Aged; Molecular Structure; Neutropenia; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Time Factors; Ultracentrifugation | 2007 |
Pharmacokinetic-pharmacodynamic target attainment analysis of cefozopran in Japanese adult patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefozopran; Cephalosporins; Female; Humans; Laparotomy; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Neutropenia | 2008 |
Development of breakpoints of cephems for intraabdominal infections based on pharmacokinetics and pharmacodynamics in the peritoneal fluid of patients.
Topics: Abdomen; Anti-Bacterial Agents; Ascitic Fluid; Cefepime; Cefotiam; Cefozopran; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Laparotomy; Microbial Sensitivity Tests; Monte Carlo Method; Postoperative Complications; Surgical Wound Infection | 2008 |
Penetration into and exposure of cefozopran in pelvic retroperitoneal space exudate.
Topics: Anti-Bacterial Agents; Area Under Curve; Cefozopran; Cephalosporins; Escherichia coli; Escherichia coli Infections; Exudates and Transudates; Female; Humans; Hysterectomy; Lymph Node Excision; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Pelvis; Postoperative Complications; Retroperitoneal Space | 2008 |
Determination of total cefozopran concentrations in human peritoneal fluid by HPLC with cefepime as an internal standard: Comparative pharmacokinetics in the fluid and plasma.
Topics: Anti-Bacterial Agents; Ascitic Fluid; Cefepime; Cefozopran; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Reference Standards; Reproducibility of Results; Ultrafiltration | 2009 |
Population pharmacokinetic modeling and pharmacodynamic assessment of cefozopran in pediatric patients.
Topics: Anti-Bacterial Agents; Bacteria; Cefozopran; Cephalosporins; Child; Drug Administration Schedule; Drug Resistance, Bacterial; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method | 2009 |
On the isomerisation of cefozopran in solution.
Topics: Anti-Bacterial Agents; Cefozopran; Cephalosporins; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Solutions; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship | 2010 |
[Repetition of Helicobacter cinaedi infections during chemotherapy for malignant lymphoma].
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cefozopran; Cephalosporins; Cyclophosphamide; Doxorubicin; Helicobacter; Helicobacter Infections; Humans; Immunocompromised Host; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasm Recurrence, Local; Ofloxacin; Prednisolone; Remission Induction; Stomach Neoplasms; Vincristine | 2010 |
A case of acne fulminans in a patient with ulcerative colitis successfully treated with prednisolone and diaminodiphenylsulfone: a literature review of acne fulminans, rosacea fulminans and neutrophilic dermatoses occurring in the setting of inflammatory
Topics: Acne Vulgaris; Anti-Inflammatory Agents; Biopsy; Cefozopran; Cephalosporins; Colitis, Ulcerative; Dapsone; Dermatologic Agents; Drug Therapy, Combination; Erythema; Fluoroquinolones; Glycolates; Humans; Male; Mesalamine; Neutrophils; Prednisolone; Quinolizines; Rosacea; Treatment Outcome; Young Adult | 2011 |
Influence of impurities on the specific optical rotation of cefozopran.
Topics: Algorithms; Anti-Bacterial Agents; Cefozopran; Cephalosporins; Chromatography, High Pressure Liquid; Drug Contamination; Optical Rotation; Reference Standards; Spectrophotometry, Ultraviolet | 2012 |
Fatal case of toxic epidermal necrolysis caused by cefozopran and associated with psoriasis.
Topics: Aged; Anti-Bacterial Agents; Cefozopran; Cephalosporins; Disseminated Intravascular Coagulation; Fatal Outcome; Female; Humans; Psoriasis; Pyelonephritis; Sepsis; Shock, Septic; Skin; Stevens-Johnson Syndrome; Ultraviolet Therapy | 2014 |
Perioperative antibiotics covering bile contamination prevent abdominal infectious complications after pancreatoduodenectomy in patients with preoperative biliary drainage.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bile; Cefazolin; Cefozopran; Cephalosporins; Colony Count, Microbial; Drainage; Female; Humans; Intraabdominal Infections; Male; Microbial Sensitivity Tests; Middle Aged; Pancreaticoduodenectomy; Preoperative Care; Prospective Studies | 2014 |
Stability studies of cefoselis sulfate in the solid state.
Topics: Air; Catalysis; Cefozopran; Cefpirome; Ceftizoxime; Cephalosporins; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Stability; Humidity; Kinetics; Sulfates; Tandem Mass Spectrometry; Temperature; Thermodynamics | 2015 |
Stability of cefozopran hydrochloride in aqueous solutions.
Topics: Cefozopran; Cephalosporins; Drug Stability; Hydrogen-Ion Concentration; Pharmaceutical Solutions; Water | 2016 |
Interspecies scaling of excretory amounts using allometry - retrospective analysis with rifapentine, aztreonam, carumonam, pefloxacin, miloxacin, trovafloxacin, doripenem, imipenem, cefozopran, ceftazidime, linezolid for urinary excretion and rifapentine,
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Carbapenems; Cefozopran; Ceftazidime; Cephalosporins; Doripenem; Feces; Fluoroquinolones; Heterocyclic Compounds, 3-Ring; Humans; Imipenem; Linezolid; Naphthyridines; Oxazines; Oxolinic Acid; Pefloxacin; Piperazines; Pyridones; Retrospective Studies; Rifampin | 2016 |
Catheter-Related Bacteremia Due to Gordonia sputi in a Patient with Acute Lymphocytic Leukemia: a Case Report.
Topics: Actinomycetales Infections; Adolescent; Anti-Bacterial Agents; Bacteremia; Blood Culture; Catheter-Related Infections; Cefozopran; Cephalosporins; Gordonia Bacterium; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; RNA, Ribosomal, 16S | 2016 |
Retrospective survey and evaluation of first-line antibiotics for chemotherapy-induced febrile neutropenia in patients with acute myeloid leukemia.
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Cefepime; Cefozopran; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Female; Humans; Male; Middle Aged; Piperacillin; Retrospective Studies | 2017 |
Liver abscess due to Sterigmatomyces halophilus in a boy with acute lymphoblastic leukemia.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Basidiomycota; Biopsy; Bone Marrow Transplantation; Cefozopran; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Child; Hematopoietic Stem Cell Transplantation; Humans; Liver; Liver Abscess; Male; Micafungin; Mycoses; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome | 2019 |
First report on multidrug-resistant non-encapsulated Streptococcus pneumoniae isolated from a patient with pneumonia.
Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Cefozopran; Cephalosporins; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Microbial Sensitivity Tests; Myopathies, Structural, Congenital; Ophthalmoplegia; Pneumonia, Pneumococcal; Ryanodine Receptor Calcium Release Channel; Sputum; Streptococcus pneumoniae; Sulbactam | 2020 |
Retrospective Cohort Study of Clinical Efficacy and Safety of Cefozopran for Treating Febrile Neutropenia during Chemotherapy in Patients with Lung Cancer.
Topics: Anti-Bacterial Agents; Cefepime; Cefozopran; Cephalosporins; Febrile Neutropenia; Humans; Lung Neoplasms; Retrospective Studies; Treatment Outcome | 2022 |